The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2

Blood

Volumn 90, Issue 3, 1997, Pages 1047-1054

  Kupfer, Gary M ^a   Yamashita, Takayuki ^b   Naf, Dieter ^b   Suliman, Ahmed ^b   Asano, Shigetaka ^b   D'Andrea, Alan D ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE;

ARTICLE; BONE MARROW DEPRESSION; CANCER RISK; CELL CYCLE; FANCONI ANEMIA; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0030831350     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.3.1047.1047_1047_1054     Document Type: Article

References (62)

1. Fanconi G: Familial constitutional panmyelocytopathy, Fanconi's anemia (FA). I. Clinical aspects. Semin Hematol 4:233, l967
2. Strathdee CA, Buchwald M: Molecular and cellular biology of Fanconi anemia. Am J Pediatr Hematol/Oncol 14:177, 1992
3. Liu J, Buchwald M, Walsh C, Young N: Fanconi anemia and novel strategies for therapy. Blood 84:3995, 1994
4. Auerbach AD: Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 21:731, 1993
5. Alter BP: Fanconi's anaemia and its variability. Br J Haematol 85:9, 1993
6. Strathdee CA, Duncan AMV, Buchwald M: Evidence for at least four Fanconi Anemia genes including FACC on chromosome 9. Nat Genet 1:196, 1992
7. Moustacchi E, Papadopoulo D, Diatloff-Zito C, Buchwald M: Two complementation groups of Fanconi's anemia differ in their phenotypic response to a DNA cross-linking treatment. Hum Genet 75:45, 1987
8. Duckworth-Rysiecki G, Cornish K, Clarke CA, Buchwald M: Identification of two complementation groups in Fanconi Anemia. Somat Cell Mol Gen 11:35, 1985
9. Joenje H, LoTen F, Oostra A, Berkel CV, Rooimans M, Schroeder S, Kurth T, Wegner R, Gille J, Buchwald M, Arwert F: Classification of Fanconi Anemia patients by complementation analysis: Evidence for a fifth genetic subtype. Blood 86:2156, 1995
10. Strathdee CA, Gavish H, Shannon W, Buchwald M: Cloning of cDNAs for Fanconi's Anemia by functional complementation (Correction). Nature 358:434, 1992
11. Strathdee CA, Gavish H, Shannon WR, Buchwald M: Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 356:763, 1992
12. The Fanconi Anaemia/Breast Cancer Consortium: Positional cloning of the Fanconi anaemia group A gene. Nature Genetics 14:324, 1996
13. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, Alon N, Wijker M, Parker L, Lightfoot J, Carreau M, Callen DF, Savoia A, Cheng NC, van Berkel CGM, Strunk MHP, Gille JJP, Pals G, Kruyt FAE, Pronk JC, Arwert F, Buchwald M, Joenje H: Expression cloning of a cDNA for the major Fanconi anemia gene, FAA. Nature Genetics 14:320, 1996
14. Whitney M, Thayer M, Reifsteck C, Oison S, Smith L, Jakobs P, Leach R, Naylor S, Joenje H, Grompe M: Microcell mediated chromosome transfer maps the Fanconi anemia group D gene to chromosome 3p. Nature Genet 11:341, 1995
15. Chen M, Tomkins DJ, Auerbach W, McKerlie C, Youssoufian H, Liu L, Can O, Carreau M, Auerbach A, Groves T, Guidos CJ, Freeman MH, Cross J, Percy DH, Dick JE, Joyner AL, Buchwald M: Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nature Genetics 12:448, 1996
16. Whitney MA, Royle G, Low MJ, Kelly MA, Axthelm MK, Reifsteck C, Oison S, Braun RE, Heinrich MC, Rathbun RK, Bagby GC, Grompe M: Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood 88:49, 1996
17. Yamashita T, Barber DL, Zhu Y, Wu N, D'Andrea AD: The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Proc Natl Acad Sci USA 91:6712, 1994
18. Youssoufian H: Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. Proc Natl Acad Sci USA 91:7975, 1994
19. Dutrillaux B, Aurias A, Dutrillaux AM, Buriot D, Prieur M: The cell cycle of lymphocytes in Fanconi anemia. Hum Genet 62:327, 1982
20. Kaiser TN, Lojewski A, Dougherty C, Juergens L, Sahar E, Latt SA: Flow cytometric characterization of the response of Fanconi's Anemia cells to mitomycin C treatment. Cytometry 2:291, 1982
21. Digweed M, Gunthert U, Schneider R, Seyschah H, Friedl R, Sperling K: Irreversible repression of DNA synthesis in Fanconi anemia cells is alleviated by the product of a novel cvclin-related gene. Mol Cell Biol 15:305, 1995
22. Sabatier L, Dutrillaux B: Effect of caffeine in Fanconi anemia: I. Restoration of a normal duration of G2 phase. Hum Genet 79:242, 1988
23. Seyschab H, Bretzel G, Friedl R, Schinlder D, Sun Y, Hoehn H: Modulation of the spontaneous G2 phase blockage in Fanconi anemia cells by caffeine: Differences from cells arresled by X-irradiation. Mutat Res 308:149, 1994
24. cdc2 activation. Cancer Res 53:1507, 1993
25. Diller L, Kassel J, Nelson Ce, Gryka MA, Wak GL, Gebhardt M, Bressac B, Oxturk M, Baker SJ, Vogelstein B, Friend SH: p53 Functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 10:5772, 1990
26. Kastan M, Zhan Q, El-Deiry W, Carrier F, Jacks T, Walsh W, Plunkett B, Vogelstein B, AJ Fornace J: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatalangiectasia. Cell 71:587, 1992
27. Kastan M, Onyekwere O, Sidransky D, Vogelstein B, Craig R: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304, 1991
28. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ: A p53-dependent mouse spindle checkpoint. Science 267:1353, 1993
29. Kruyt FAE, Dijkmans LM, van den Berg TK, Joenje H: Fanconi Anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. Blood 87:938, 1996
30. Kupfer GM, D' Andrea AD: The effect of the Fanconi Anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation. Blood 88:1019, 1996
31. Hirama T, Koeffler HP: Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841, 1995
32. cdc2: The S and M kinase? New Biologist 2:389, 1990
33. Moreno S, Hayles J, Nurse P: Regulation of p34cdc2 protein kinase during mitosis. Cell 58:361, 1989
34. Ducommun B, Brambilla P, Felix MA Jr, Franza BR Jr, Karsenti E, Draetta G: cdc2 phosphorylation is required for its interaction with cyclin. EMBO J 10:3311, 1991
35. Blangy A, Lane HA, d'Herin P, Harper M, Kress M, Nigg EA: Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell 83:1159, 1995
36. 2 arrest in Chinese hamster ovary cells. Cancer Res 50:3761, 1990
37. Nishio K, Fujiwara Y, Miyahara Y, Takeda Y, Ohira T, Kubota N, Ohta S, Funayama Y, Ogasawara H, Ohata M, Saijo N: Cis-diamminedichloroplatinum(II) inhibits p34cdc2 protein kinase in human lung cancer cells. Int J Cancer 55:616, 1993
38. Herzinger T, Funk JO, Hillmer K, Eick D, Wolf DA, Kind P: Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinase. Oncogene 11:2151, 1995
39. cdc2/Cyclin B. Cancer Res 52:1823, 1992
40. cdc2 kinase in etoposide-induced cell death of Chinese hamster ovary cells. Cancer Res 50:3767, 1990
41. Rowley R, Hudson J, Young PG: The weel protein kinase is required for radiation-induced mitotic delay. Nature 356:353, 1992
42. White RJ, Gottlieb TM, Downes CS, Jackson SP: Cell cycle regulation of RNA polymerase III. Mol Cell Biol 15:6653, 1995
43. Yamashita T, Wu N, Kupfer G, Corless C, Joenje H, Grompe M, D'Andrea AD: The Clinical Variability of Fanconi Anemia (Type C) results from expression of an amino terminal truncated FAC polypeptide with partial activity. Blood 87:4424, 1996
44. D'Andrea AD, Yoshimura A, Youssoufian H, Zon LI, Koo J-W, Lodish HF: The cytoplasmic region of the erythropoietin receptor contains non-overlapping positive and negative growth regulatory domains. Mol Cell Biol 11:1980, 1991
45. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 72:248, 1976
46. Draetta G, Beach D: Activation of cdc2 protein kinase during mitosis in human cells; cell cycle-dependent phosphorylation and subunit rearrangement. Cell 54:17, 1988
47. Gavish H, dos Santos CC, Buchwald M: A Leu554-to-Pro substitution completely abolishes the functional complementing activity of the Fanconi anemia (FACC) protein. Hum Mol Genet 2:123, 1993
48. Foe LT, Rooimans MA, Joenje H, Arwert F: A novel frameshift mutation (1806insA) in exon 14 of the Fanconi anemia C gene. Hum Mutat 7:264, 1996
49. Foe LT, Barel MT, Tuss P, Digweed M, Arwert F, Joenje H: Sequence variations in the Fanconi anaemia gene, FAC: Pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variant. Hum Genet 98:522, 1996
50. Youssoufian H, Auerbach AD, Verlander PC, Steimle V, Mach B: Identification of cytosolic proteins that bind to the Fanconi Anemia complementation group C polypeptide in vitro. J Biol Chem 270:9876, 1995
51. King RW, Peters JM, Tugendreich S, Rolfe M, Hieter P, Kirschner MW: A 2OS complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell 81:279, 1995
52. Heald R. McLoughlin M, McKeon F: Human weel maintains mitotic timing by protecting the nucleus from cytoplasmically activated cdc2 kinase. Cell 74:463, 1993
53. cdc2-mitotic B cyclin complex. Cell 78:813, 1994
54. Rime H, Jessus C, Ozon R: Tyrosine phosphorylation of p34cdc2 is regulated by protein phosphatase 2A in growing immature Xenopus oocytes. Exp Cell Res 219:29, 1995
55. Montelone BA, Koelliker KJ: Interactions among mutations affecting spontaneous mutation, mitotic recombination, and DNA repair in yeast. Curr Genet 27:102, 1995
56. Kozhina T, Kozhin S, Stepanova V, Yarovoy B, Donich V, Fedorova I, Korolev V: UVS112-a gene involved in excision repair of yeast. Yeast 11:1129, 1995
57. Heude M, Chanet R, Fabre F: Regulation of Saccharomyces cerevisiae Srs2 helicase during the mitotic cell cycle, meiosis, and after irradiation. Mol Gen Genet 248:59, 1995
58. 2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and Cyclin B1/cdc2-kinase complexes differently. J Biol Chem 268:8298, 1993
59. O'Connor PM, Ferns DK, White GA, Pines J, Hunter T, Longo DL, Kohn KW: Relationships between cdc2 kinase, DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard. Cell Growth Differ 3:43, 1992
60. MacLachlan TK, Sang N, Giordano A: Cyclins, cyclin-dependent kinases and cdk inhibitors: Implications in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr 5:127, 1995
61. Kip1, to regions involved in human cancer. Cancer Res 55:1199, 1995
62. Kaiser TN, Lojewski A, Dougherty C, Juergens L, Sahar E, Latt SA: Flow cytometric characterization of the response of Fanconi's Anemia cells to mitomycin C treatment. Cytometry 2:291, 1982